Search
for
Sort by
Research 451–480 of 1000+
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Pre-receptor regulation of the androgen receptor
- Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- BIOLOGICAL ACTIVITY OF ANTIANDROGENS
- Intraoperative floppy-iris syndrome and finasteride intake
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II
- Clinical application of 5α-reductase inhibitors
- New 5?-reductase inhibitors: In vitro and in vivo effects
- 5α-Reductases In Human Physiology: an Unfolding Story
- Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Finasteride
- Finasteride and sexual side effects
- Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite
- 5-Alpha reductase deficiency
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Acute liver damage due to <i>Serenoa repens</i>: a case report
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Improvement in androgenetic alopecia in 53-76-year-old men using oral finasteride
- Oral ivermectin in the treatment of scabies
- Finasteride-associated cataract and intraoperative floppy-iris syndrome